Diabetes Research Yielding Breakthrough Success Medical News Today - Mar 18 4:16 PM
Freedom from insulin injections and the myriad of health problems related to type 1 diabetes is closer to becoming reality, thanks to University of Calgary researchers who are developing the first bioreactor procedures to grow pancreatic cells in their laboratory. This opens the door to the possibility of providing a steady supply of insulin-producing cells that can be transplanted into patients Save to My Web
AmCham: Deutschland f r US-Investoren attraktiver geworden Finanztreff.de - Mar 16 4:53 AM
FOSTER CITY, CA -- (MARKET WIRE) -- 03/16/2006 -- Entelos, Inc., a leader in predictive biosimulation technologies for drug discovery, development, and commercialization, announced today that it has expanded its research collaboration with Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD) to include multiple therapeutic areas over a five-year term.Save to My Web
US consumer inflation up 0.1% India Daily - Mar 16 2:59 PM
Consumer prices in the US rose by just 0.1 per cent in February, suggesting that inflationary pressures remain contained and raising hopes that the Federal Reserve may soon be able to stop lifting interest rates.Save to My Web
Northeast/Central weekly calendar El Paso Times - Mar 17 2:09 AM
All calendar items are in El Paso unless otherwise stated. Alcoholics Anonymous, call for details. 562-4081, (505) 589-1058, 757-3327, 595-9940, and 838-6264 (Spanish).Save to My Web
New Torcetrapib/Atorvastatin Research Further Supports Raising "Good" HDL Cholesterol Medical News Today - Mar 16 4:12 PM
Pfizer said today that new data, involving its medicine in development torcetrapib/atorvastatin, provides important information on the benefit of raising HDL, or "good" cholesterol, while simultaneously lowering LDL, or "bad" cholesterol. These new findings may play a critical role in reducing the burden of cardiovascular disease and potentially improving quality of life for patients... click Save to My Web